Analytical Data
-
基因名
A30L
- Application
-
别名
(Protein A30)
-
种属
Monkeypox virus
-
表达系统
E. coli
-
标签
N- His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8V4U9
-
表达区间
22-146aa
-
分子量
18.2 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The A30L protein, a vital component of the African swine fever virus (ASFV), has garnered significant attention in virology and immunology research due to its potential role in viral pathogenesis and immune evasion strategies. ASFV, a highly contagious and lethal pathogen affecting domestic and wild pigs, poses a critical threat to global swine production and food security. A30L is known to modulate host immune responses, particularly by inhibiting the interferon signaling pathway, which is a key component of the host's antiviral defense. Understanding the structure and function of A30L is crucial for elucidating its mechanisms in immune evasion and developing effective vaccines or therapeutic strategies. Recent advances in recombinant protein technology have enabled the production of A30L for detailed biochemical and structural studies, allowing researchers to assess its interactions with host proteins and its effects on cellular signaling pathways. The insights gained from these studies may pave the way for novel approaches to combat ASFV and improve the resilience of swine populations against this devastating disease. As the global incidence of ASF continues to rise, research on A30L not only contributes to basic virology but also has practical implications for controlling outbreaks and protecting livestock industries worldwide.
